ACRV ▲ +1.0% - Acrivon Therapeutics, Inc. $ACRV - Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer Acrivon Therapeutics shares rose 1.0% following the company's appointment of Michaela Levin, Ph.D., as Chief Business Officer. The leadership addition appears to have been received positively by investors, though the headline does not specify Levin's background or experience that may have prompted the market response. 31-AUG-2026 08:30 AM ET